Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors

International Journal of Cancer

Volumn 93, Issue 3, 2001, Pages 445-449

  Koch, Arend ^a   Waha, Anke ^a   Tonn, Jörg C ^b   Sörensen, Nils ^b   Berthold, Frank ^c   Wolter, Marietta ^a   Reifenberger, Julia ^d   Hartmann, Wolfgang ^a   Friedl, Waltraut ^a   Reifenberger, Guido ^a   Wiestler, Otmar D ^a   Pietsch, Torsten ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

catenin; APC; Medulloblastoma; Turcot's syndrome

Indexed keywords

AMINO ACID; APC PROTEIN; BETA CATENIN; CYSTEINE; GLUTAMIC ACID; GLUTAMINE; LEUCINE; PROLINE; SERINE;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CELL PROLIFERATION; CHILD; CODON; GENE MUTATION; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; MISSENSE MUTATION; NERVOUS SYSTEM DEVELOPMENT; NEUROECTODERM TUMOR; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SOMATIC MUTATION;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ADOLESCENT; ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BETA CATENIN; BLOTTING, WESTERN; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; CYTOSKELETAL PROTEINS; DNA, NEOPLASM; EXONS; FEMALE; GENE FREQUENCY; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; MALE; MEDULLOBLASTOMA; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NEUROECTODERMAL TUMORS, PRIMITIVE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 0035427076     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1342     Document Type: Article

References (45)

1. Posterior fossa brain tumors in children
2. Turcot syndrome and familial adenomatous polyposis associated with brain tumor: Review of related literature
3. Signal transduction of beta-catenin
4. Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes
5. Activation of β-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC
6. Beta-catenin as oncogene: The smoking gun
7. Identification of c-MYC as a target of the APC pathway
8. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
9. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein
10. Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly
11. Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations
12. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma
13. Loss of β-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene
14. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer
15. Stabilization of β-catenin by genetic defects in melanoma cell lines
16. Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the APC gene
17. Characterization of 5 new cell lines derived from human primitive neuroectodermal tumors of the central nervous system
18. Microsatellite analysis of loss of heterozygosity on chromosomes 9q, 11p and 17p in medulloblastomas
19. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the β-catenin gene
20. Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE
21. Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched
22. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)
23. Deletion mapping of the medulloblastoma locus on chromosome 17p
24. Molecular analysis of the lissencephaly gene 1 (LIS-1) in medulloblastomas
25. Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas
26. Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system
27. The molecular basis of Turcot syndrome
28. Germ-line and somatic mutations of the APC gene in patients with Turcot syndrome and analysis of APC mutations in brain tumors
29. The APC gene in Turcot syndrome
30. Hepatoblastoma and APC gene mutation in familial adenomatous polyposis
31. Mutations of the APC (adenomatous polyposis coli) gene
32. Somatic mutation of the APC gene in gastric cancer: Frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma
33. APC mutations in sporadic medulloblastomas
34. The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history
35. Sporadic medulloblastomas contain oncogenic beta-catenin mutations
36. 2+ pathways
37. Expression of the neurotrophin receptor p75NTR in medulloblastomas is correlated with distinct histological and clinical features: Evidence for a medulloblastoma subtype derived from the external granule cell layer
38. Nuclear localization and mutation of β-catenin in medulloblastomas
39. A common human skin tumour is caused by activating mutations in beta-catenin
40. Beta-catenin mutation in carcinoma of the uterine endometrium
41. Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3
42. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas
43. Beta-catenin mutations in human prostate cancer